Tuesday January 14, 2020 12:00pm to 1:00pm
Join an upcoming webinar for further details on the current funding opportunities available, and find out about how to apply to joint transnational calls with the European Commission:
Should you have any questions or for more information, please contact the CIHR Contact Centre (firstname.lastname@example.org)
The Canadian Institutes of Health Research continues its long-standing collaboration with the European Commission by supporting nine joint transnational calls in 2020. The Canadian dedicated funding will support the involvement of Canadian researchers in multinational research consortia in key areas such as: rare diseases, neurodegenerative diseases, cardiovascular diseases, intergenerational inequalities, sensory disorders, neuroscience (ethical, legal, and social aspects), smart living environments and transitions in care, antimicrobial resistance, and aging (with support of digital solutions).
The research collaboration is part of the EU Framework Programme Horizon 2020. As a third country, Canada/CIHR engages in Horizon 2020 predominantly through Public to Public (P2P) networks involving EU member states, other third and associated countries, and the European Commission. CIHR is currently involved in fifteen P2P networks within the health sector. Since 2010, CIHR has participated in 48 joint transnational calls and has funded over 145 multinational teams. The organization has invested over $45 million, and has committed an additional $6.7 million to the joint transnational calls in 2019 and $7 million to the nine joint transnational calls in 2020.
Horizon Europe will come into effect in 2021 and will be the biggest multilateral research and innovation programme in the world, with a proposed budget allocation of almost €100 billion, an increase of almost 30% (when adjusted for inflation) from Horizon 2020.